CD4 and coinfection: While the high prevalence highlights the known risks of viral exposure in dialysis settings, the observed associations between HPgV-1 infection and favorable co-infection markers—such as lower liver enzyme levels in HCV co-infection and higher CD4+ counts in HIV—suggest a potential immunomodulatory role for the virus that warrants further investigation.